Revvity Inc. (RVTY)
Pretax margin
Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|
Earnings before tax but after interest (EBT) | US$ in thousands | 696,567 | 708,340 | 1,257,300 | 897,399 | 236,947 |
Revenue | US$ in thousands | 2,750,570 | 3,311,820 | 3,827,810 | 3,782,740 | 2,883,670 |
Pretax margin | 25.32% | 21.39% | 32.85% | 23.72% | 8.22% |
December 31, 2023 calculation
Pretax margin = EBT ÷ Revenue
= $696,567K ÷ $2,750,570K
= 25.32%
The pretax margin of Revvity Inc. has displayed fluctuations over the past five years. The trend indicates a decrease in the pretax margin from 25.26% in January 2, 2022, to 6.65% in December 31, 2023. This decline suggests a potential decrease in the company's profitability before accounting for taxes in recent years. Further investigation into the factors influencing this trend, such as changes in revenue, expenses, or cost management strategies, could provide valuable insights into Revvity Inc.'s financial performance and sustainability.
Peer comparison
Dec 31, 2023
Company name
Symbol
Pretax margin
Revvity Inc.
RVTY
25.32%
Avantor Inc
AVTR
5.89%
Bio-Rad Laboratories Inc
BIO
-16.04%
Bruker Corporation
BRKR
18.38%
Cytek Biosciences Inc
CTKB
-8.14%
Illumina Inc
ILMN
-24.80%
Mettler-Toledo International Inc
MTD
25.70%
Waters Corporation
WAT
25.90%